StockData

Innospec vs Quaker Chemical

IOSP and KWR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IOSP and KWR compare

Quaker Chemical is the larger company, worth 1.4 times as much as Innospec ($2.6B against $1.9B).

Quaker Chemical grew revenue faster over the last twelve months (8.7% versus 2.9% for Innospec).

Both pay dividends: Innospec yields 3.5% and Quaker Chemical 1.4%.

Innospec scores higher on the StockData Score (13 against 10 for Quaker Chemical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIOSPKWR
Size and price
Market cap$1.9B$2.6B
Share price$78.01$151.08
Change, 1 year5.3%13.5%
Change, 5 years−6.2%−36.3%
Beta (5Y)1.101.02
Employees2,4504,700
StockData Score
Total score13 (better)10
Valuation score33
Growth score1 (better)0
Performance score11
Health score6 (better)2
Dividend score24 (better)
Valuation
P/E–26.9×
P/S1.0× (better)1.3×
P/B1.4× (better)1.8×
EV/EBITDA9.9× (better)14.8×
P/FCF–65.9×
FCF yield–1.5%
Fair value$92.08$149.01
Margin of safety15.3% (better)−1.4%
Growth
Revenue growth (TTM)2.9%8.7% (better)
Revenue growth, 5Y average8.3% (better)5.9%
EPS growth, 5Y average32.1%–
Profitability
Gross margin27.5%35.8% (better)
Operating margin7.0%7.6% (better)
Net margin–4.8%
FCF margin–1.9%
Return on equity–7.0%
Return on invested capital10.4% (better)5.2%
Financial health
Debt / equity0.000.63 (better)
Net debt / EBITDA–3.23
Interest coverage–3.8×
Current ratio2.78 (better)2.47
Altman Z-score4.85 (better)2.48
Piotroski F-score–5
Dividends and buybacks
Dividend yield3.5% (better)1.4%
Payout ratio–36.2%
Years of dividend growth1216 (better)
Dividend growth, 5Y average10.5% (better)5.0%
Buyback yield1.3%–
Shareholder yield4.8% (better)1.4%
Ownership
Held by institutions101%91.9%
Held by insiders1.6%22.4%
Insider net buying, 12 months−$874K−$208K (better)
Short interest, % of float1.9%12.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.